The President Has ADD or ADHD 7-12-25
In this episode, Scott Becker explores President Trump’s impulsive decisions and their impact on the markets.
Rebounding from a Bad Day of Eating 7-11-25
In this episode, Scott shares a personal story about the struggles of eating healthy while on vacation.
Twitter Poll: Is It Too Late to Invest in NVIDIA?? 7-11-25
In this brief episode, Scott Becker shares the results of a Twitter poll exploring whether it’s too late to invest in NVIDIA.
13 Stories We Are Following Today 7-11-25
In this rapid-fire episode, Scott Becker shares 13 key updates including market shifts, the surge in Bitcoin, value-based care skepticism, social media trends, and more.
Should You Double Down on Microsoft, NVIDIA, or Bitcoin? 7-11-25
In this episode, Scott Becker poses a timely investment question: with Microsoft, NVIDIA, and Bitcoin trading near all-time highs, is now the moment to double down or hold back? Listeners are invited to weigh in for a chance to win an Amazon gift card.
Focus, Reflection, and High-Stakes Litigation with David Pivnick of McGuireWoods LLP 7-10-25
In this episode, David Pivnick, Partner at McGuireWoods LLP, discusses how a major false claims trial is shaping his focus for the second half of the year.
Delta and the Airlines Take Off 7-10-25
In this episode, Scott Becker discusses a sharp stock rise for Delta, American, and United Airlines, driven by Delta’s emphasis on profitability through premium pricing.
Learning From Business Failures 7-10-25
In this episode, Scott Becker reflects on three key business missteps shared during a keynote fireside chat with NextLevel Exchange in Chicago.
The Markets, NVIDIA, and Tesla All Pointing Up 7-10-25
In this episode, Scott Becker shares a quick market update, highlighting NVIDIA’s historic $4 trillion valuation, Tesla’s modest rebound despite a rough year, and overall positive movement in the markets amid political noise.
Mid-Year Healthcare Private Equity Trends with Amber Walsh 7-9-25
In this episode, Amber Walsh, Partner at McGuireWoods LLP, joins Scott Becker to discuss healthcare deal activity in the first half of 2025. She shares insights on rising deal values, sector-specific momentum in tech and biotech, and shifting dynamics in physician specialties and private equity exit strategies.